Compare GFAI & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFAI | CLGN |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | Singapore | Israel |
| Employees | 1657 | N/A |
| Industry | Diversified Commercial Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 5.2M |
| IPO Year | 2020 | 2015 |
| Metric | GFAI | CLGN |
|---|---|---|
| Price | $0.17 | $3.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 200.9K | 49.9K |
| Earning Date | 09-23-2026 | 11-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.88 | N/A |
| Revenue Next Year | $5.00 | $25.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.26 |
| 52 Week High | $0.98 | $4.78 |
| Indicator | GFAI | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 27.97 | 55.59 |
| Support Level | N/A | $0.34 |
| Resistance Level | $0.41 | $4.64 |
| Average True Range (ATR) | 0.02 | 0.36 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 5.95 | 49.61 |
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.